Discovery offers hope for treatment of dyslexia - A gene which is likely to be one of the causes of dyslexia in children has been discovered by researchers at Cardiff University. They believe the major finding will give researchers a better understanding of what causes the brain disorder which disru...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Adults suffering from dyslexia can benefit from tutoring in processing words, and their brains show changes that indicate neural modifications due to the training, researchers have found. Guinevere Eden and her colleagues said that their studies indicate that adult dyslexics can be helped by trainin...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease, particularly among...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Avidia Inc., a privately held biopharmaceutical company, today announced the initiation of and dosing of the first patient for a Phase I clinical trial of its novel drug candidate C326, an inhibitor of interleukin-6 for the treatment of Crohn's disease. C326 is the first in a new class of therapeuti...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
In comparison to cystic fibrosis (CF) patients who regularly use inhaled corticosteroid, those who did not use these drugs for six months exhibited no positive or negative effects in terms of major disease factors. Such factors include amount of lung function decline, number of antibiotics prescribe...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Pam Miles, a public relationsexecutive who lived in Memphis for 13 years, has Cystic Fibrosis and mustundergo a complete lung transplant within the next six months in order tolive. A corps of volunteers, led by members of the Public Relations Societyof America, has mobilized to raise $200,000 to cov...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
New treatments are normally tested on adults before they are tested on children. A paper by doctors involved in gene therapy for cystic fibrosis argues that approach could be wrong. "We could be denying children life enhancing treatment on inadequate grounds" said lead author Dr Adam Jaffe. There is...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Eurand, aspecialty pharmaceutical company, today announced the initiation of thesecond of two Phase 3 clinical trials required for registration of itspancreatic enzyme product (PEP), EUR-1008, in patients with exocrinepancreatic insufficiency (EPI). EPI is a deficiency of digestive enzymesnormally p...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Canada has among the highest incidences of ulcerative colitis and Crohn's disease cases per capita in the world, a new study shows.About one in 350 Canadians suffer from ulcerative colitis or Crohn's disease, otherwise known collectively as Inflammatory Bowel Disease (IBD), the study shows. The stud...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.
